Background: Cerebrospinal fluid (CSF) lactate is frequently used as a biomarker in
| INTRODUCTION
Cerebrospinal fluid (CSF) lactate is being increasingly evaluated as a potential biomarker of central nervous system (CNS) disease in dogs.
Normative data and reference intervals for CSF lactate concentrations have been reported in dogs. [1] [2] [3] [4] There are increases in CSF lactate concentrations in dogs with severe cognitive deficits, 5 and a trend to increasing values was noted in dogs with intracranial disease. 1 However, another study failed to detect a difference in CSF lactate values between dogs with or without structural intracranial disease. 6 Outside these few studies performed in small numbers of dogs, there is little information available related to CSF lactate in diseased dogs.
In humans, CSF lactate concentrations are increased in a variety of CNS disorders including mitochondrial disorders, inflammatory conditions, head trauma, and seizures. [7] [8] [9] [10] [11] Perhaps, the greatest utility in humans is to distinguish bacterial from aseptic meningitis. 12, 13 However, lactate concentrations are also increased in some patients with presumed autoimmune inflammatory conditions such as neuromyelitis optica 14 and multiple-sclerosis. [15] [16] [17] [18] Recently, a handheld lactate monitor has been validated for quantification of L-lactate in canine blood and CSF and a CSF reference interval for this analyte has been established (1.02-2.49 mmol/L). 4, 19 The purpose of this study was to evaluate CSF lactate concentrations in dogs with inflammatory CNS diseases. We hypothesized that many of these CSF samples would have lactate concentrations above the upper end of our established reference interval.
| MATERIALS AND METHODS

| Animals, CSF sample collection, CSF analysis and outcome determination
Dogs that were referred to the NC State Veterinary Hospital for a variety of presenting complaints were included in the study. Inclusion 
| Meningoencephalitis of unknown etiology
This diagnosis was made in dogs with suspected granulomatous meningoencephalitis (GME), necrotizing meningoencephalitis (NME), or necrotizing leukoencephalitis (NLE) but in which histopathology of the nervous system was not performed. In these cases, the diagnosis was based on CNS imaging and CSF evaluation. 22 
| Meningomyelitis
These cases were similar to MUE cases but with primary involvement of the spinal cord.
| Total MUE
As MUE is a clinical term used to indicate dogs suspected to have GME, NME, or NLE that do not have a histological diagnosis and many use the term MUE to encompass dogs with spinal cord involvement, dogs in the MUE, GME/NME/NLE, and meningomyelitis groups were combined to create this group.
| Steroid-responsive meningitis-arteritis
For inclusion, dogs with SRMA had to be less than 3 years of age at pre- 
| Infectious or presumed infectious meningoencephalitis or meningomyelitis
These dogs had evidence of CNS inflammation together with a positive test for an infectious disease, which might have included testing of blood or CSF for antigen, antibody titers, nucleic acids via polymerase chain reaction-based testing, or microscopic visualization of organisms in a clinical sample. Presumed infectious cases included dogs that had a clinical response to antibiotic administration without concurrent glucocorticoid or other anti-inflammatory or immunosuppressive medications.
| Miscellaneous
This group included dogs with idiopathic tremor syndrome, idiopathic hypertrophic pachymeningitis, eosinophilic meningoencephalitis, and 1 dog with a histologically confirmed infiltrative inflammatory condition involving the paraspinal musculature, meninges, and cervical spinal cord.
| Statistical analysis
Descriptive statistics were generated for age at presentation, weight, All analyses were conducted using Prism (Version 7, GraphPad Software, Inc, La Jolla, California).
| RESULTS
A total of 102 dogs with a diagnosis of inflammatory CNS disease were included, with a variety of breeds represented. Descriptive statistics for individual diagnostic groups and the whole cohort are shown in Table 1 . Lesions were localized to the following locations: The CSF lactate results are shown in Table 3 . There was only 1 dog with a confirmed diagnosis of bacterial meningitis, and the lactate concentration was 11.7 mmol/L. There was no significant difference in lactate concentrations between the diagnostic groups (P = .48) and no obvious relationship between lactate and breed (data not shown). Significant but weak correlations were noted between CSF lactate concentration and nucleated cell count (r = .33, P < .001), absolute large mononuclear cell count (r = .44, P < .001), absolute small mononuclear cell count (r = .39, P < .001), absolute neutrophil cell count (r = .24, P = .01), and protein (r = .44, P < .001). No correlation was found between CSF lactate concentration and red blood cell count (P = .58).
Eighty-one of 102 dogs (79.4%) survived to hospital discharge.
Thirty-nine dogs (38.2%) died or were euthanized, and 63 (61.8%)
were censored in the survival analysis. Survival times for the diagnostic groups are shown in Table 4 and Figure 1 . When considering all diagnostic groups, there was a significant difference in survival, but this was primarily driven by the short survival in the group that had a histological diagnosis, an obvious confounding factor. When this group was removed or when the total MUE group was compared with the non-MUE groups, there was no significant difference in survival (P = .31). There was no correlation between lactate concentration and overall survival (P = .27) or difference in concentrations between those dogs that did or did not survive to hospital discharge (P = .58).
In addition, although there was some divergence of the survival curves (Figure 1) , survival was not different between dogs with lactate concentrations within or above the reference interval (P = .38).
| DISCUSSION
We found that 47% of dogs with inflammatory CNS disease had CSF lactate concentrations above our established reference interval and that this proportion did not vary substantially between diagnostic groups. The CSF lactate concentration correlated weakly with CSF nucleated cell counts and protein but not with red blood cell counts.
Cerebrospinal fluid lactate concentrations were not associated with overall survival or survival to hospital discharge.
Two prior studies of CSF lactate have been performed in dogs with intracranial disease with conflicting results. 1, 6 However, both studies evaluated small numbers of dogs with a variety of disorders (11 and 13 dogs with documented structural disease), and it is not surprising that the results varied. Meningoencephalitis was diagnosed in only 2 and 4 of the dogs in these studies, precluding reasonable comparison to our results.
Lactate has been extensively studied in human CSF and is increased in a number of conditions, including mitochondrial disorders, head F I G U R E 1 Survival curves for (A) the whole cohort of dogs with inflammatory CNS disease and (B) dogs with MUE, meningomyelitis, or histologically diagnosed GME, NME, or NLE (TMUE). There was no difference in survival of dogs with (C) inflammatory CNS disease and either normal CSF lactate (solid line) or increased CSF lactate (dashed line) (P = .74) or (D) TMUE dogs with either normal CSF lactate (solid line) or increased CSF lactate (dashed line) (P = .52). Ticks represent dogs that were censored during analysis. CNS, central nervous system; CSF, cerebrospinal fluid; GME, granulomatous meningoencephalitis; MUE, meningoencephalitis of unknown etiology; NLE, necrotizing leukoencephalitis; NME, necrotizing meningoencephalitis; SRMA, steroid responsive meningitis-arteritis; TMUE, total MUE trauma, and inflammatory conditions. [8] [9] [10] [11] Indeed, one of the greatest utilities of this analyte is distinguishing bacterial from aseptic meningitis, a common clinical conundrum in humans. 12, 13 The only dog in our study with a confirmed diagnosis of bacterial meningitis had a CSF lactate concentration of 11.7 mmol/L. It is also possible that bacterial infections went undetected in some of the dogs in this study. However, this seems unlikely as bacteria were not observed on cytological examination; most samples displayed a mononuclear pleocytosis and a majority of animals responded favorably to prolonged immunosuppressive treatment.
Cerebrospinal fluid lactate is increased in subsets of human patients with multiple sclerosis (MS), a well-known, immune-mediated inflammatory CNS disorder. 15, 17, 18 This can occur in patients with both primary progressive and remitting-relapsing forms of the disease, particularly during exacerbations, relapses, or with secondary progression. 17, 18 Despite this, a number of MS patients have CSF lactate concentrations within established reference intervals. 15, 16, 25 However, even when CSF lactate concentrations remain within normal reference intervals, these concentrations can be higher than those seen in control groups. 16, 18 In addition, CSF lactate concentrations have been correlated with injury severity as measured by progression/disability scores, 16 markers of neuronal damage, 16 and the presence of inflammatory plaques on MRI. This study did not find a consistent relationship between CSF lactate and prognosis, looking at either overall survival or survival to hospital discharge. Survival analyses in clinical veterinary patients must be interpreted cautiously as most dogs experienced euthanasia as opposed to natural death, which is driven by a number of factors including owner preferences and financial constraints. This study is no exception, and it is possible that we were unable to detect a true relationship between CSF lactate, disease severity, and prognosis due to these confounding factors.
As previous canine studies showed that blood contamination was unlikely to alter standard CSF variables with red blood cell counts less than 13 230 cells/μL 32 and human studies have suggested that even marked blood contamination has no effect on lactate concentrations, 33, 34 we chose not to exclude cases with red blood cell contamination in this study. In addition, a preliminary analysis comparing red blood cell counts and lactate concentrations showed a complete lack of correlation (n = 102, P = .86, Spearman r = .018), and we further observed that many substantially blood-contaminated samples had lactate concentrations within the reference interval.
There are several limitations of this study. First, there is some ambiguity in terms of the diagnoses being made by using clinical parameters for most cases instead of histopathology. However, we used well-established clinical guidelines for establishing these diagnoses. 23, [35] [36] [37] Additionally, the histopathology group closely resembled the others in terms of the distribution and range of CSF lactate concentrations. Finally, inclusion of a few incorrect diagnoses would be unlikely to substantially alter the main results or conclusions of the study. Secondly, we did not account for the potential effect of seizure activity on CSF lactate concentrations, which has been shown to alter this analyte in some human studies. 38, 39 The effect of seizures on CSF lactate in dogs requires further study. A third limitation relates to the potential effect of blood lactate on CSF lactate. Prior studies in experimental animals and humans have demonstrated that lactate does not freely cross the blood-brain or blood-CSF barriers, [40] [41] [42] [43] and instead relies on monocarboxylic acid transport systems. 44 As a result, blood and CSF lactate concentrations are relatively independent. Although there are few studies available in dogs, the prior study that validated the Lactate Plus meter for canine CSF showed that although CSF and blood lactate were correlated, this correlation was very weak. 4 Therefore, although blood lactate concentrations might have influenced CSF concentrations, we suspect that this influence was minimal.
However, this relationship also warrants further study.
In conclusion, approximately half of all the dogs with inflammatory CNS disorders as well as those with MUE had increased CSF lactate concentrations. The Lactate Plus monitor provides a useful method of obtaining a rapid analysis of this analyte with very small sample volumes, potentially facilitating the diagnosis of MUE in the hospital.
Cerebrospinal fluid lactate was weakly correlated with CSF nucleated cell counts and protein but not with red blood cell counts and did not show a consistent relationship with survival. The mechanisms by which CSF lactate is increased in dogs with inflammatory CNS disorders might include microbial infection, lymphocyte proliferation, and mitochondrial dysfunction but require additional study.
